NMNH(Reduced Nicotinamide Mononucleotide)
NMNH(Reduced Nicotinamide Mononucleotide)
FOB
MOQ:
1
Shipping:
Express Delivery, Air freight, Ocean freight
Sample:Free supportGet samples
Product details
Essential details
MOQ:1
G.W:28 kg
Lead time:2-3
N.W:25 kg
Shipping:Express Delivery, Air freight, Ocean freight
Specification Number:99%
Package Description:内PE袋, 外纸桶
Product Introduction
Introduction to NMNH (Reduced Nicotinamide Mononucleotide) in Cosmetics

NMNH (Reduced Nicotinamide Mononucleotide), also known as β-Nicotinamide Mononucleotide (reduced form), is a biologically active compound derived from nicotinamide adenine dinucleotide (NAD⁺), a coenzyme critical for cellular energy metabolism and DNA repair. In cosmetics, NMNH has gained attention for its potential anti-aging, antioxidant, and skin-rejuvenating properties. Below is an overview of its role in cosmetic formulations:

1. Key Properties & Benefits

  • Antioxidant Activity: NMNH neutralizes free radicals, protecting the skin from oxidative stress caused by environmental factors (e.g., UV radiation, pollution), which contributes to premature aging and dullness.
  • Anti-Aging Effects: By replenishing intracellular NAD⁺ levels, NMNH supports cellular energy production (mitochondrial function) and activates sirtuins (enzymes linked to longevity), promoting collagen synthesis and reducing fine lines/wrinkles.
  • Skin Barrier Enhancement: It improves skin hydration and elasticity by supporting keratinocyte differentiation and lipid biosynthesis, addressing dryness and restoring the skin’s protective barrier.
  • Cellular Repair & Regeneration: NMNH accelerates DNA repair mechanisms, aiding in post-inflammatory skin recovery and reducing the appearance of damage (e.g., hyperpigmentation, uneven texture).

2. Mechanism of Action

NMNH acts as a direct precursor to NAD⁺, bypassing rate-limiting steps in its biosynthesis. Topical application allows NMNH to penetrate the skin (via passive diffusion or carrier systems), where it is converted to NAD⁺. Elevated NAD⁺ levels:

  • Activate sirtuins (SIRT1-SIRT7), regulating gene expression for anti-aging and stress resistance.
  • Fuel cellular processes (e.g., glycolysis, citric acid cycle) essential for skin health and renewal.
  • Support the Nrf2 pathway, enhancing antioxidant defenses and detoxification.

3. Cosmetic Applications

  • Formulations: Commonly found in serums, creams, masks, and anti-aging treatments.
  • Target Skin Concerns: Aging (wrinkles, loss of elasticity), dryness, oxidative damage, uneven tone, and post-acne scarring.
  • Synergistic Ingredients: Often paired with hyaluronic acid (hydration), retinol (collagen stimulation), peptides (firming), and antioxidants (e.g., vitamin C, resveratrol) for enhanced efficacy.

4. Safety & Stability

  • Non-Irritating: Generally well-tolerated by most skin types; suitable for sensitive skin when formulated appropriately.
  • Stability: The reduced form (NMNH) is more stable than the oxidized form (NMN) in cosmetic matrices, resisting degradation from light and heat.
  • Clinical Support: Studies suggest topical NMNH improves skin hydration, elasticity, and texture without significant side effects (source: preclinical and observational data).

5. Future Trends

Research explores NMNH’s potential in:

  • Photoaging prevention (protection against UV-induced damage).
  • Microbiome modulation (supporting skin microbial balance).
  • Transdermal delivery systems (liposomes, nanocarriers) to enhance penetration and bioavailability.

Conclusion

NMNH represents a promising ingredient in cosmeceuticals, merging scientific understanding of NAD⁺ biology with skincare innovation. Its ability to boost cellular energy, combat oxidation, and promote rejuvenation positions it as a key component in next-generation anti-aging formulations. As formulations evolve, NMNH is likely to become a staple in premium skincare targeting holistic skin health.

References:

  • Preclinical studies on NAD⁺ precursors in dermatology (e.g., Journal of Cosmetic Dermatology).
  • Cosmetic ingredient databases (INCID: pending; CAS: 1094-61-7 for NMN, reduced form specifics may vary).


Product details
NMNH(Reduced Nicotinamide Mononucleotide)
Leave your information and we will contact you.

About us

Services and Vision

Timeline with us

Licenses and Certificates

Products

Contact Us

Email:  shellyzeng@jinhoubio.com

Tell/Whatsapp:  +86 18273766827

Address: Group 7, Baisha Xi Village, Tianzhuang Township, Anhua County, Yiyang City 413000, Hunan Province, China

Tel
WhatsApp
Email